FKBP1C as A Potential Drug Target for Various Diseases (G642489)

FKBP1C as A Potential Drug Target for Various Diseases

FKBP1C (BA184C23.2), also known as FKBP1C gene or FKBP1C protein, is a gene that encodes a protein known as FKBP1C. FKBP1C is a key regulator of protein translation in cells and is involved in the process of protein folding. It is a protein that is expressed in almost all cells, including brain, heart, and muscle cells, and is also expressed in various bodily tissues and organs.

The FKBP1C gene has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This is because FKBP1C is involved in the regulation of cellular processes that are often disrupted in these diseases, and may provide a useful target for therapeutic intervention.

One of the reasons why FKBP1C has been identified as a potential drug target is its involvement in the regulation of protein translation, which is the process by which cells produce new proteins from the instructions contained in DNA. Protein translation is a critical process that is required for the development and maintenance of all cells, and is often disrupted in diseases such as cancer, neurodegenerative diseases, and autoimmune diseases.

In cancer, FKBP1C has been shown to play a role in the regulation of protein translation and has been identified as a potential drug target for cancer therapy. For example, studies have shown that inhibiting FKBP1C can lead to the production of fewer and less aggressive cancer cells. This is because FKBP1C is involved in the regulation of the translation of proteins that are involved in cell growth and division, and inhibiting its activity can lead to the production of fewer and less aggressive cancer cells.

In neurodegenerative diseases, FKBP1C has been shown to be involved in the regulation of protein translation and has been identified as a potential drug target for these diseases. For example, studies have shown that inhibiting FKBP1C can lead to the production of fewer and less harmful neurodegenerative proteins. This is because FKBP1C is involved in the regulation of the translation of proteins that are involved in the development and maintenance of the nervous system, and inhibiting its activity can lead to the production of fewer and less harmful neurodegenerative proteins.

In autoimmune diseases, FKBP1C has been shown to play a role in the regulation of protein translation and has been identified as a potential drug target for these diseases. For example, studies have shown that inhibiting FKBP1C can lead to the production of fewer and less autoimmune -related proteins. This is because FKBP1C is involved in the regulation of the translation of proteins that are involved in the development and maintenance of immune systems, and inhibiting its activity can lead to the production of fewer and less autoimmune-related proteins.

In conclusion, FKBP1C is a gene that encodes a protein that is involved in the regulation of protein translation and has been identified as a potential drug target or biomarker for various diseases. Its involvement in these diseases makes it an attractive target for therapeutic intervention, and further research is needed to understand its role in the development and progression of these diseases.

Protein Name: FKBP Prolyl Isomerase Family Member 1C

The "FKBP1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKBP1C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5 | FNDC7 | FNDC8 | FNDC9 | FNIP1